Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P200028/S026

DiamondTemp Ablation System

Medtronic, Inc. · Decision date Oct 10, 2025

FDA DECISIONP200028/S026

What did the FDA approve?

FDA records P200028/S026 as a supplement to PMA P200028, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Oct 10, 2025.

FDA approval order statement

approval of the revised protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P200028.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track No User Fee
Clinical specialty
Cardiovascular
Decision date
Oct 10, 2025
FDA change category
Postapproval Study Protocol

FDA source record

Regulatory record facts

Identifier
P200028/S026
Regulatory pathway
PMA supplement
Product code
OAE
Decision code
APPR
Decision date
Oct 10, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Catheter, percutaneous, cardiac ablation, for treatment of atrial fibrillation.

Product code
OAE
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P200028/S026 received

    Application receipt date recorded by FDA.

  2. P200028/S026 · FDA decision

    Normal 180 Day Track No User Fee

Timeline entries are records held by MedtechLedger for P200028. View FDA’s full supplement list.

Related devices and submissions

Explore the linked device profile

Other records with product code OAE

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
8200 Coral Sea St., Mounds View, MN, 55112

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records